Patents by Inventor Steven Grant

Steven Grant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12135426
    Abstract: The present application discloses a system and device for displaying content. The system includes an optical unit that is wearable. The optical unit includes a magnifying lens, a front light, and a display. The front light illuminates the display from the front of the display to be observable by a user via the magnifying lens.
    Type: Grant
    Filed: August 15, 2022
    Date of Patent: November 5, 2024
    Assignee: Sindarin, Inc.
    Inventors: Trae Benjamin Stephens, Benjamin Eli Nelson Chelf, Nicholas Cory Johnson, John Aaron Boiles, Nicholas Grant Lewis, Kevin Robert McKinney, Steven David Oliver, Tun Yuen Yeung, Keith Alsberg, Jeremiah O'Leary
  • Patent number: 12131008
    Abstract: A method for configuring a system having a wearable optical unit is disclosed. The method includes powering on the system, and in response to the system being powered on, using one or more processors to control the system to: determine whether to cause the system to run a configuration workflow, and in response to determining to cause the system to run the configuration workflow, (a) control the system in connection with configuring an interpupillary distance (IPD) for a user of the system, (b) determine whether the IPD is configured for the user, and (c) in response to determining that the IPD is configured for the user, control the system in connection with configuring a focus of the optical unit.
    Type: Grant
    Filed: October 11, 2022
    Date of Patent: October 29, 2024
    Assignee: Sindarin, Inc.
    Inventors: Trae Benjamin Stephens, Benjamin Eli Nelson Chelf, Nicholas Cory Johnson, John Aaron Boiles, Nicholas Grant Lewis, Kevin Robert McKinney, Steven David Oliver, Tun Yuen Yeung, Meghan Easley, Robin Porter, Jeremiah O'Leary, Keith Alsberg, Robert Samuel Clay
  • Patent number: 12129295
    Abstract: The invention relates to an antigen binding site for binding to a P2X7 receptor, the antigen binding site being defined by general formula 1: FR1-CDR1-FR2-CDR2-FR3-CDR3-FR4.
    Type: Grant
    Filed: March 10, 2021
    Date of Patent: October 29, 2024
    Assignee: BIOSCEPTRE (AUST) PTY LTD
    Inventors: Julian Alexander Barden, Neil Brewis, Philip Jones, Steven Grant
  • Publication number: 20240352303
    Abstract: Cement compositions comprising a modified styrenic block copolymers and methods for making/using the same are disclosed. The modified styrenic block copolymer has at least one monoalkenyl arene polymer block A, at least one conjugated diene polymer block B, and at least an epoxy functional group or derivative thereof. The modified styrenic block copolymer has a degree of epoxidation of up to 10-90%. The cement composition can be used in subterranean applications, as well as in building and construction materials. The modified styrenic block copolymers swell upon contact water or other aqueous fluids to seal cracks in the cement.
    Type: Application
    Filed: April 18, 2024
    Publication date: October 24, 2024
    Applicant: Kraton Corporation
    Inventors: Stephanie Grant, David Germack, Steven Huynh
  • Patent number: 11976113
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Grant
    Filed: August 7, 2020
    Date of Patent: May 7, 2024
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Steven Grant, Martin Orecchia, Chika Akinseye, Laura Hook, Alan Lewis, Tejinder Bhinder
  • Patent number: 11613571
    Abstract: The present disclosure relates to compositions comprising antibody variants, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Grant
    Filed: May 21, 2019
    Date of Patent: March 28, 2023
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Chika Akinseye, Tejinder Bhinder, Li Cui, Steven Grant, Laura Hook, Alan Peter Lewis, Martin Anibal Orecchia
  • Publication number: 20220315652
    Abstract: The invention relates to an antigen binding site for binding to a P2X7 receptor, the antigen binding site being defined by general formula 1: FR1-CDR1-FR2-CDR2-FR3-CDR3-FR4
    Type: Application
    Filed: March 10, 2021
    Publication date: October 6, 2022
    Applicant: BIOSCEPTRE (AUST) PTY LTD
    Inventors: Julian Alexander Barden, Neil Brewis, Philip Jones, Steven Grant
  • Publication number: 20220073636
    Abstract: Antibody polypeptides that specifically bind human CD40L are provided. The antibody polypeptides do not activate platelets. The antibody polypeptides are useful in the treatment of diseases involving CD40L activation, such as graft-related diseases and autoimmune diseases. The antibody polypeptides may be domain antibodies (dAbs) comprising a single VH or VK domain. The half-life of the antibody polypeptides may be increased by modifying the antibody polypeptides to be dual specific reagents that can also bind human serum albumin (HSA) or another antigen.
    Type: Application
    Filed: November 9, 2021
    Publication date: March 10, 2022
    Inventors: Steven G. NADLER, James K. TAMURA, Laura PRICE, Robert P. REHFUSS, Suzanne J. SUCHARD, Anish SURI, James William BRYSON, Aaron YAMNIUK, Steven GRANT, Olga IGNATOVICH, Philip DREW
  • Patent number: 11180567
    Abstract: Antibody polypeptides that specifically bind human CD40L are provided. The antibody polypeptides do not activate platelets. The antibody polypeptides are useful in the treatment of diseases involving CD40L activation, such as graft-related diseases and autoimmune diseases. The antibody polypeptides may be domain antibodies (dAbs) comprising a single VH or VK domain. The half-life of the antibody polypeptides may be increased by modifying the antibody polypeptides to be dual specific reagents that can also bind human serum albumin (HSA) or another antigen.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: November 23, 2021
    Assignees: Bristol-Myers Squibb Company, Domantis Limited
    Inventors: Steven G. Nadler, James K. Tamura, Laura Price, Robert P. Rehfuss, Suzanne J. Suchard, Anish Suri, James William Bryson, Aaron Yamniuk, Steven Grant, Olga Ignatovich, Philip Drew
  • Patent number: 11136406
    Abstract: Antibody polypeptides that specifically bind a novel epitope of human CD40 are provided. The antibody polypeptides do not exhibit CD40 agonist activity. The antibody polypeptides are useful in the treatment of diseases involving CD40 activation, such as autoimmune diseases. The antibody polypeptides may be domain antibodies (dAbs) comprising a single VL or VH domain. The half-life of the antibody polypeptides may be increased by modifying the antibody polypeptides to be dual specific reagents that can also bind human serum albumin (HSA).
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: October 5, 2021
    Assignees: Bristol-Myers Squibb Company, Domantis Limited
    Inventors: Anish Suri, Steven Sheriff, Suzanne Suchard, Aaron Yamniuk, Stanley Krystek, James Tamura, James Bryson, Steven Grant, Philip Drew
  • Patent number: 10988532
    Abstract: The invention relates to an antigen binding site for binding to a P2X7 receptor, the antigen binding site being defined by general formula 1: FR1-CDR1-FR2-CDR2-FR3-CDR3-FR4.
    Type: Grant
    Filed: July 11, 2018
    Date of Patent: April 27, 2021
    Assignee: BIOSCEPTRE (AUST) PTY LTD
    Inventors: Julian Alexander Barden, Neil Brewis, Philip Jones, Steven Grant
  • Publication number: 20210115128
    Abstract: The present disclosure relates to compositions comprising antibody variants, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Application
    Filed: May 21, 2019
    Publication date: April 22, 2021
    Inventors: Chika AKINSEYE, Tejinder BHINDER, Li CUI, Steven GRANT, Laura HOOK, Alan Peter LEWIS, Martin Anibal ORECCHIA
  • Publication number: 20210017269
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Application
    Filed: August 7, 2020
    Publication date: January 21, 2021
    Inventors: Steven GRANT, Martin ORECCHIA, Chika AKINSEYE, Laura HOOK, Alan LEWIS, Tejinder BHINDER
  • Patent number: 10787509
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: September 29, 2020
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Steven Grant, Martin Orecchia, Chika Akinseye, Laura Hook, Alan Lewis, Tejinder Bhinder
  • Publication number: 20200199244
    Abstract: Antibody polypeptides that specifically bind a novel epitope of human CD40 are provided. The antibody polypeptides do not exhibit CD40 agonist activity. The antibody polypeptides are useful in the treatment of diseases involving CD40 activation, such as autoimmune diseases. The antibody polypeptides may be domain antibodies (dAbs) comprising a single VL or VH domain. The half-life of the antibody polypeptides may be increased by modifying the antibody polypeptides to be dual specific reagents that can also bind human serum albumin (HSA).
    Type: Application
    Filed: December 20, 2019
    Publication date: June 25, 2020
    Inventors: Anish SURI, Steven SHERIFF, Suzanne SUCHARD, Aaron YAMNIUK, Stanley KRYSTEK, James TAMURA, James BRYSON, Steven GRANT, Philip DREW
  • Patent number: 10619913
    Abstract: A body cooling assembly for cooling parts of a body includes a belt that is extendable around a waist. A housing is mounted on the belt includes a top wall, a bottom wall and a perimeter wall that extends between and is attached to the top and bottom wall. The housing has a first aperture and a second aperture for taking in and expelling air. A cooling unit is mounted in the housing. When actuated the cooling unit draws air into the housing, cools the air and dispends the cold air outwardly. A plurality of tubes is fluidly coupled to the housing and in thermal communication with the cooling unit such that air moves through the cooling unit and exits the housing through the tubes. The tubes are positionable on parts of a body and have a plurality of vent holes wherein each tube releases air.
    Type: Grant
    Filed: October 4, 2017
    Date of Patent: April 14, 2020
    Inventors: Michael Grant, Steven Grant, Sr.
  • Patent number: 10544228
    Abstract: Antibody polypeptides that specifically bind a novel epitope of human CD40 are provided. The antibody polypeptides do not exhibit CD40 agonist activity. The antibody polypeptides are useful in the treatment of diseases involving CD40 activation, such as autoimmune diseases. The antibody polypeptides may be domain antibodies (dAbs) comprising a single VL or VH domain. The half-life of the antibody polypeptides may be increased by modifying the antibody polypeptides to be dual specific reagents that can also bind human serum albumin (HSA).
    Type: Grant
    Filed: September 8, 2016
    Date of Patent: January 28, 2020
    Assignees: Bristol-Myers Squibb Company, Domantis Limited
    Inventors: Anish Suri, Steven Sheriff, Suzanne Suchard, Aaron Yamniuk, Stanley Krystek, James Tamura, James Bryson, Steven Grant, Philip Drew
  • Publication number: 20190100595
    Abstract: Antibody polypeptides that specifically bind human CD40L are provided. The antibody polypeptides do not activate platelets. The antibody polypeptides are useful in the treatment of diseases involving CD40L activation, such as graft-related diseases and autoimmune diseases. The antibody polypeptides may be domain antibodies (dAbs) comprising a single VH or VK domain. The half-life of the antibody polypeptides may be increased by modifying the antibody polypeptides to be dual specific reagents that can also bind human serum albumin (HSA) or another antigen.
    Type: Application
    Filed: December 12, 2018
    Publication date: April 4, 2019
    Inventors: Steven G. NADLER, James K. TAMURA, Laura PRICE, Robert P. REHFUSS, Suzanne J. SUCHARD, Anish SURI, James William BRYSON, Aaron YAMNIUK, Steven GRANT, Olga IGNATOVICH, Philip DREW
  • Publication number: 20190101322
    Abstract: A body cooling assembly for cooling parts of a body includes a belt that is extendable around a waist. A housing is mounted on the belt includes a top wall, a bottom wall and a perimeter wall that extends between and is attached to the top and bottom wall. The housing has a first aperture and a second aperture for taking in and expelling air. A cooling unit is mounted in the housing. When actuated the cooling unit draws air into the housing, cools the air and dispends the cold air outwardly. A plurality of tubes is fluidly coupled to the housing and in thermal communication with the cooling unit such that air moves through the cooling unit and exits the housing through the tubes. The tubes are positionable on parts of a body and have a plurality of vent holes wherein each tube releases air.
    Type: Application
    Filed: October 4, 2017
    Publication date: April 4, 2019
    Inventors: Michael Grant, Steven Grant, SR.
  • Publication number: 20190040129
    Abstract: The invention relates to an antigen binding site for binding to a P2X7 receptor, the antigen binding site being defined by general formula 1: FR1-CDR1-FR2-CDR2-FR3-CDR3-FR4
    Type: Application
    Filed: July 11, 2018
    Publication date: February 7, 2019
    Inventors: Julian Alexander Barden, Neil Brewis, Philip Jones, Steven Grant